934 Index
Neuroleptic-induced parkinsonism, 709
Neuroleptic malignant syndrome, 22, 709–711
development and course of, 710
diagnostic features of, 710
differential diagnosis of, 711
risk and prognostic factors for, 711
Night eating syndrome, 354
Nightmare disorder, 361, 404–407
associated features supporting diagnosis of, 405
comorbidity with, 407
culture-related diagnostic issues in, 406
development and course of, 405
diagnostic criteria for, 404
diagnostic features of, 404–405
diagnostic markers for, 406
differential diagnosis of, 406–407
functional consequences of, 406
gender-related diagnostic issues in, 406
prevalence of, 405
relationship to International Classification of 
Sleep Disorders, 407
risk and prognostic factors for, 405
Nonadherence to medical treatment, 22, 726–727
Non–rapid eye movement sleep arousal 
disorders, 361, 399–404
associated features supporting diagnosis of, 
400–401
comorbidity with, 403
development and course of, 401
diagnostic criteria for, 399
diagnostic features of, 400
diagnostic markers for, 402
differential diagnosis of, 402–403
functional consequences of, 402
gender-related diagnostic issues in, 401
prevalence of, 401
relationship to International Classification of 
Sleep Disorders, 404
risk and prognostic factors for, 401
Nonsuicidal self-injury, 803–805
development and course of, 804
diagnostic features of, 804
differential diagnosis of, 805–806
functional consequences of, 805